<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02258360</url>
  </required_header>
  <id_info>
    <org_study_id>PROID7005</org_study_id>
    <nct_id>NCT02258360</nct_id>
  </id_info>
  <brief_title>Hypothermia and Hemostasis After Cardiac Arrest</brief_title>
  <official_title>The Effect of Therapeutic Hypothermia After Cardiac Arrest on the Haemostasis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <brief_summary>
    <textblock>
      This is a sub-study to the Time-differentiated Therapeutic Hypothermia (TTH48,
      ClinicalTrials.gov Identifier: NCT01689077). TTH48 compares 24 with 48 hours of therapeutic
      hypothermia at a target temperature of 32-34°C in survivors of out-of-hospital cardiac
      arrest.

      The overall aim of this sub-study is to examine the hemostasis in patients resuscitated after
      cardiac arrest and treated with 24 and 48 hours of therapeutic hypothermia

      Our specific aims are:

        -  To investigate the whole blood coagulation using the rotational thromboelastometry.

        -  To investigate the function of platelets
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clotting time in seconds, EXTEM</measure>
    <time_frame>After 46 hours</time_frame>
    <description>Measured by thomboelastometry on the ROTEM®</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area under the curve, COL-test</measure>
    <time_frame>After 46 hours</time_frame>
    <description>Platelet function will be measured using Multiplate®</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clotting time in seconds, EXTEM</measure>
    <time_frame>After 22 hours and 70 hours</time_frame>
    <description>Measured by thomboelastometry on the ROTEM®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clotting time in seconds, -INTEM, FIBTEM and HEPTEM</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
    <description>Measured by thomboelastometry on the ROTEM®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clot formation time in seconds, -EXTEM, INTEM, FIBTEM and HEPTEM</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
    <description>Measured by thomboelastometry on the ROTEM®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum clot firmness (mm), -EXTEM, INTEM, FIBTEM and HEPTEM</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
    <description>Measured by thomboelastometry on the ROTEM®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the curve, COL-test</measure>
    <time_frame>After 22 hours and 70 hours</time_frame>
    <description>Platelet function will be measured using Multiplate®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the curve,- ADP, ASPI and TRAP-test.</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
    <description>Platelet function will be measured using Multiplate®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to maximum velocity (s), -EXTEM, INTEM, FIBTEM and HEPTEM</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
    <description>Measured by thomboelastometry on the ROTEM®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum velocity (mm/min), -EXTEM, INTEM, FIBTEM and HEPTEM</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
    <description>Measured by thomboelastometry on the ROTEM®.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the curve, Clot stability test</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area under the curve, Thrombin generation</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>International normalized ratio</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>APTT (activated partial thromboplastin time) in seconds</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fibrinogen in mol/l</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Antithrombin in 10^3 int.units/l</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>D-dimer in mg/l FEU</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Trombine time in seconds</measure>
    <time_frame>After 22 hours, 46 hours and 70 hours</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Hypothermia</condition>
  <condition>Heart Arrest</condition>
  <condition>Hemostasis</condition>
  <condition>Coagulants</condition>
  <arm_group>
    <arm_group_label>24 hours hypothermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapeutic hypothermia for 24 hours after reaching target temperature</description>
  </arm_group>
  <arm_group>
    <arm_group_label>48 hours hypothermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Therapeutic hypothermia for 48 hours after reaching target temperature</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Therapeutic hypothermia</intervention_name>
    <description>Therapeutic hypothermia with a target temperature between 32-34°C.</description>
    <arm_group_label>24 hours hypothermia</arm_group_label>
    <arm_group_label>48 hours hypothermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Out of hospital cardiac arrest of presumed cardiac cause

          -  Return of spontaneous circulation (ROSC)

          -  Glasgow Coma Score &lt; 8

          -  Age &gt; 18 years and &lt; 80 years

        Exclusion Criteria:

          -  &gt; 60 minutes from the circulatory collapse to ROSC

          -  Time interval &gt; 4 hours from cardiac arrest to initiation of therapeutic hypothermia

          -  Terminal illness

          -  Coagulation disorder

          -  Unwitnessed asystolia

          -  Cerebral performance category 3-4 before the cardiac arrest

          -  Severe persistent cardiogenic shock

          -  Pregnancy

          -  Persistent cardiogenic shock (systolic blood pressure &lt; 80 despite inotropic
             treatment)

          -  New apoplexy or intracerebral hemorrhage

          -  Lack of consent from the relatives

          -  Lack of consent from the GP

          -  Lack of consent from the patient if he/she wakes up and is relevant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anni Norgaard Jeppesen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Center of Emergency Medicine and Department of Anesthesiology and Intensive Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dept of Anesthesiology and Intensive Care and Dept of Clinical Biochemistry, Aarhus University Hospital, Skejby</name>
      <address>
        <city>Aarhus</city>
        <state>Aarhus N</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 29, 2014</study_first_submitted>
  <study_first_submitted_qc>October 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2014</study_first_posted>
  <last_update_submitted>March 28, 2016</last_update_submitted>
  <last_update_submitted_qc>March 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thromboelastometry</keyword>
  <keyword>Haemostasis</keyword>
  <keyword>Hypothermia</keyword>
  <keyword>Heart Arrest</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Hypothermia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

